Compile Data Set for Download or QSAR
maximum 50k data
Found 1422 of ph data with Target = 'Prostaglandin D2 receptor 2'
TargetProstaglandin D2 receptor 2(Homo sapiens (Human))
Actelion Pharmaceuticals

US Patent
LigandPNGBDBM205944(US9255090, 413)
Affinity DataIC50:  0.800nMpH: 7.0 T: 2°CAssay Description:Binding assay was performed in a final assay volume of 250 ul. First, 25 ul of test compound, previously diluted in Binding-Buffer (Binding-Buffer: 5...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetProstaglandin D2 receptor 2(Homo sapiens (Human))
Actelion Pharmaceuticals

US Patent
LigandPNGBDBM205945(US9255090, 414)
Affinity DataIC50:  430nMpH: 7.0 T: 2°CAssay Description:Binding assay was performed in a final assay volume of 250 ul. First, 25 ul of test compound, previously diluted in Binding-Buffer (Binding-Buffer: 5...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetProstaglandin D2 receptor 2(Homo sapiens (Human))
Actelion Pharmaceuticals

US Patent
LigandPNGBDBM205946(US9255090, 415)
Affinity DataIC50:  337nMpH: 7.0 T: 2°CAssay Description:Binding assay was performed in a final assay volume of 250 ul. First, 25 ul of test compound, previously diluted in Binding-Buffer (Binding-Buffer: 5...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetProstaglandin D2 receptor 2(Homo sapiens (Human))
Actelion Pharmaceuticals

US Patent
LigandPNGBDBM205947(US9255090, 416)
Affinity DataIC50:  575nMpH: 7.0 T: 2°CAssay Description:Binding assay was performed in a final assay volume of 250 ul. First, 25 ul of test compound, previously diluted in Binding-Buffer (Binding-Buffer: 5...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetProstaglandin D2 receptor 2(Homo sapiens (Human))
Actelion Pharmaceuticals

US Patent
LigandPNGBDBM205948(US9255090, 417)
Affinity DataIC50:  23.5nMpH: 7.0 T: 2°CAssay Description:Binding assay was performed in a final assay volume of 250 ul. First, 25 ul of test compound, previously diluted in Binding-Buffer (Binding-Buffer: 5...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetProstaglandin D2 receptor 2(Homo sapiens (Human))
Actelion Pharmaceuticals

US Patent
LigandPNGBDBM205949(US9255090, 418)
Affinity DataIC50:  352nMpH: 7.0 T: 2°CAssay Description:Binding assay was performed in a final assay volume of 250 ul. First, 25 ul of test compound, previously diluted in Binding-Buffer (Binding-Buffer: 5...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetProstaglandin D2 receptor 2(Homo sapiens (Human))
Actelion Pharmaceuticals

US Patent
LigandPNGBDBM205950(US9255090, 419)
Affinity DataIC50:  2.80nMpH: 7.0 T: 2°CAssay Description:Binding assay was performed in a final assay volume of 250 ul. First, 25 ul of test compound, previously diluted in Binding-Buffer (Binding-Buffer: 5...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetProstaglandin D2 receptor 2(Homo sapiens (Human))
Actelion Pharmaceuticals

US Patent
LigandPNGBDBM205951(US9255090, 420)
Affinity DataIC50:  2.40nMpH: 7.0 T: 2°CAssay Description:Binding assay was performed in a final assay volume of 250 ul. First, 25 ul of test compound, previously diluted in Binding-Buffer (Binding-Buffer: 5...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetProstaglandin D2 receptor 2(Homo sapiens (Human))
Actelion Pharmaceuticals

US Patent
LigandPNGBDBM205952(US9255090, 421)
Affinity DataIC50:  3.80nMpH: 7.0 T: 2°CAssay Description:Binding assay was performed in a final assay volume of 250 ul. First, 25 ul of test compound, previously diluted in Binding-Buffer (Binding-Buffer: 5...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetProstaglandin D2 receptor 2(Homo sapiens (Human))
Actelion Pharmaceuticals

US Patent
LigandPNGBDBM205953(US9255090, 422)
Affinity DataIC50:  8.5nMpH: 7.0 T: 2°CAssay Description:Binding assay was performed in a final assay volume of 250 ul. First, 25 ul of test compound, previously diluted in Binding-Buffer (Binding-Buffer: 5...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetProstaglandin D2 receptor 2(Homo sapiens (Human))
Actelion Pharmaceuticals

US Patent
LigandPNGBDBM205954(US9255090, 423)
Affinity DataIC50:  180nMpH: 7.0 T: 2°CAssay Description:Binding assay was performed in a final assay volume of 250 ul. First, 25 ul of test compound, previously diluted in Binding-Buffer (Binding-Buffer: 5...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetProstaglandin D2 receptor 2(Homo sapiens (Human))
Actelion Pharmaceuticals

US Patent
LigandPNGBDBM205955(US9255090, 424)
Affinity DataIC50:  444nMpH: 7.0 T: 2°CAssay Description:Binding assay was performed in a final assay volume of 250 ul. First, 25 ul of test compound, previously diluted in Binding-Buffer (Binding-Buffer: 5...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetProstaglandin D2 receptor 2(Homo sapiens (Human))
Actelion Pharmaceuticals

US Patent
LigandPNGBDBM205956(US9255090, 425)
Affinity DataIC50:  11.3nMpH: 7.0 T: 2°CAssay Description:Binding assay was performed in a final assay volume of 250 ul. First, 25 ul of test compound, previously diluted in Binding-Buffer (Binding-Buffer: 5...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetProstaglandin D2 receptor 2(Homo sapiens (Human))
Actelion Pharmaceuticals

US Patent
LigandPNGBDBM205957(US9255090, 426)
Affinity DataIC50:  1.90nMpH: 7.0 T: 2°CAssay Description:Binding assay was performed in a final assay volume of 250 ul. First, 25 ul of test compound, previously diluted in Binding-Buffer (Binding-Buffer: 5...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetProstaglandin D2 receptor 2(Homo sapiens (Human))
Actelion Pharmaceuticals

US Patent
LigandPNGBDBM205958(US9255090, 427)
Affinity DataIC50:  3.10nMpH: 7.0 T: 2°CAssay Description:Binding assay was performed in a final assay volume of 250 ul. First, 25 ul of test compound, previously diluted in Binding-Buffer (Binding-Buffer: 5...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetProstaglandin D2 receptor 2(Homo sapiens (Human))
Actelion Pharmaceuticals

US Patent
LigandPNGBDBM205959(US9255090, 428)
Affinity DataIC50:  3.70nMpH: 7.0 T: 2°CAssay Description:Binding assay was performed in a final assay volume of 250 ul. First, 25 ul of test compound, previously diluted in Binding-Buffer (Binding-Buffer: 5...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetProstaglandin D2 receptor 2(Homo sapiens (Human))
Actelion Pharmaceuticals

US Patent
LigandPNGBDBM205960(US9255090, 429)
Affinity DataIC50:  50.7nMpH: 7.0 T: 2°CAssay Description:Binding assay was performed in a final assay volume of 250 ul. First, 25 ul of test compound, previously diluted in Binding-Buffer (Binding-Buffer: 5...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetProstaglandin D2 receptor 2(Homo sapiens (Human))
Actelion Pharmaceuticals

US Patent
LigandPNGBDBM205961(US9255090, 430)
Affinity DataIC50:  14.9nMpH: 7.0 T: 2°CAssay Description:Binding assay was performed in a final assay volume of 250 ul. First, 25 ul of test compound, previously diluted in Binding-Buffer (Binding-Buffer: 5...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetProstaglandin D2 receptor 2(Homo sapiens (Human))
Actelion Pharmaceuticals

US Patent
LigandPNGBDBM205962(US9255090, 431)
Affinity DataIC50:  1.40nMpH: 7.0 T: 2°CAssay Description:Binding assay was performed in a final assay volume of 250 ul. First, 25 ul of test compound, previously diluted in Binding-Buffer (Binding-Buffer: 5...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetProstaglandin D2 receptor 2(Homo sapiens (Human))
Actelion Pharmaceuticals

US Patent
LigandPNGBDBM205963(US9255090, 432)
Affinity DataIC50:  5.30nMpH: 7.0 T: 2°CAssay Description:Binding assay was performed in a final assay volume of 250 ul. First, 25 ul of test compound, previously diluted in Binding-Buffer (Binding-Buffer: 5...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetProstaglandin D2 receptor 2(Homo sapiens (Human))
Actelion Pharmaceuticals

US Patent
LigandPNGBDBM205964(US9255090, 433)
Affinity DataIC50:  59.3nMpH: 7.0 T: 2°CAssay Description:Binding assay was performed in a final assay volume of 250 ul. First, 25 ul of test compound, previously diluted in Binding-Buffer (Binding-Buffer: 5...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetProstaglandin D2 receptor 2(Homo sapiens (Human))
Actelion Pharmaceuticals

US Patent
LigandPNGBDBM205965(US9255090, 434)
Affinity DataIC50:  0.700nMpH: 7.0 T: 2°CAssay Description:Binding assay was performed in a final assay volume of 250 ul. First, 25 ul of test compound, previously diluted in Binding-Buffer (Binding-Buffer: 5...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetProstaglandin D2 receptor 2(Homo sapiens (Human))
Actelion Pharmaceuticals

US Patent
LigandPNGBDBM205966(US9255090, 435)
Affinity DataIC50:  2.60nMpH: 7.0 T: 2°CAssay Description:Binding assay was performed in a final assay volume of 250 ul. First, 25 ul of test compound, previously diluted in Binding-Buffer (Binding-Buffer: 5...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetProstaglandin D2 receptor 2(Homo sapiens (Human))
Actelion Pharmaceuticals

US Patent
LigandPNGBDBM205967(US9255090, 436)
Affinity DataIC50:  5.40nMpH: 7.0 T: 2°CAssay Description:Binding assay was performed in a final assay volume of 250 ul. First, 25 ul of test compound, previously diluted in Binding-Buffer (Binding-Buffer: 5...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetProstaglandin D2 receptor 2(Homo sapiens (Human))
Actelion Pharmaceuticals

US Patent
LigandPNGBDBM205968(US9255090, 437)
Affinity DataIC50:  10.9nMpH: 7.0 T: 2°CAssay Description:Binding assay was performed in a final assay volume of 250 ul. First, 25 ul of test compound, previously diluted in Binding-Buffer (Binding-Buffer: 5...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetProstaglandin D2 receptor 2(Homo sapiens (Human))
Actelion Pharmaceuticals

US Patent
LigandPNGBDBM205969(US9255090, 438)
Affinity DataIC50:  3.70nMpH: 7.0 T: 2°CAssay Description:Binding assay was performed in a final assay volume of 250 ul. First, 25 ul of test compound, previously diluted in Binding-Buffer (Binding-Buffer: 5...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetProstaglandin D2 receptor 2(Homo sapiens (Human))
Actelion Pharmaceuticals

US Patent
LigandPNGBDBM205970(US9255090, 439)
Affinity DataIC50:  126nMpH: 7.0 T: 2°CAssay Description:Binding assay was performed in a final assay volume of 250 ul. First, 25 ul of test compound, previously diluted in Binding-Buffer (Binding-Buffer: 5...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetProstaglandin D2 receptor 2(Homo sapiens (Human))
Actelion Pharmaceuticals

US Patent
LigandPNGBDBM205971(US9255090, 440)
Affinity DataIC50:  3.80nMpH: 7.0 T: 2°CAssay Description:Binding assay was performed in a final assay volume of 250 ul. First, 25 ul of test compound, previously diluted in Binding-Buffer (Binding-Buffer: 5...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetProstaglandin D2 receptor 2(Homo sapiens (Human))
Actelion Pharmaceuticals

US Patent
LigandPNGBDBM205972(US9255090, 441)
Affinity DataIC50:  17.5nMpH: 7.0 T: 2°CAssay Description:Binding assay was performed in a final assay volume of 250 ul. First, 25 ul of test compound, previously diluted in Binding-Buffer (Binding-Buffer: 5...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetProstaglandin D2 receptor 2(Homo sapiens (Human))
Actelion Pharmaceuticals

US Patent
LigandPNGBDBM205973(US9255090, 442)
Affinity DataIC50:  5.30nMpH: 7.0 T: 2°CAssay Description:Binding assay was performed in a final assay volume of 250 ul. First, 25 ul of test compound, previously diluted in Binding-Buffer (Binding-Buffer: 5...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetProstaglandin D2 receptor 2(Homo sapiens (Human))
Actelion Pharmaceuticals

US Patent
LigandPNGBDBM205974(US9255090, 443)
Affinity DataIC50:  18.1nMpH: 7.0 T: 2°CAssay Description:Binding assay was performed in a final assay volume of 250 ul. First, 25 ul of test compound, previously diluted in Binding-Buffer (Binding-Buffer: 5...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetProstaglandin D2 receptor 2(Homo sapiens (Human))
Actelion Pharmaceuticals

US Patent
LigandPNGBDBM205975(US9255090, 444)
Affinity DataIC50:  2nMpH: 7.0 T: 2°CAssay Description:Binding assay was performed in a final assay volume of 250 ul. First, 25 ul of test compound, previously diluted in Binding-Buffer (Binding-Buffer: 5...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetProstaglandin D2 receptor 2(Homo sapiens (Human))
Actelion Pharmaceuticals

US Patent
LigandPNGBDBM205976(US9255090, 445)
Affinity DataIC50:  2.5nMpH: 7.0 T: 2°CAssay Description:Binding assay was performed in a final assay volume of 250 ul. First, 25 ul of test compound, previously diluted in Binding-Buffer (Binding-Buffer: 5...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetProstaglandin D2 receptor 2(Homo sapiens (Human))
Actelion Pharmaceuticals

US Patent
LigandPNGBDBM205977(US9255090, 446)
Affinity DataIC50:  4.70nMpH: 7.0 T: 2°CAssay Description:Binding assay was performed in a final assay volume of 250 ul. First, 25 ul of test compound, previously diluted in Binding-Buffer (Binding-Buffer: 5...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetProstaglandin D2 receptor 2(Homo sapiens (Human))
Actelion Pharmaceuticals

US Patent
LigandPNGBDBM205978(US9255090, 447)
Affinity DataIC50:  78.2nMpH: 7.0 T: 2°CAssay Description:Binding assay was performed in a final assay volume of 250 ul. First, 25 ul of test compound, previously diluted in Binding-Buffer (Binding-Buffer: 5...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetProstaglandin D2 receptor 2(Homo sapiens (Human))
Actelion Pharmaceuticals

US Patent
LigandPNGBDBM205979(US9255090, 448)
Affinity DataIC50:  9.20nMpH: 7.0 T: 2°CAssay Description:Binding assay was performed in a final assay volume of 250 ul. First, 25 ul of test compound, previously diluted in Binding-Buffer (Binding-Buffer: 5...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetProstaglandin D2 receptor 2(Homo sapiens (Human))
Actelion Pharmaceuticals

US Patent
LigandPNGBDBM205980(US9255090, 449)
Affinity DataIC50:  14.2nMpH: 7.0 T: 2°CAssay Description:Binding assay was performed in a final assay volume of 250 ul. First, 25 ul of test compound, previously diluted in Binding-Buffer (Binding-Buffer: 5...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetProstaglandin D2 receptor 2(Homo sapiens (Human))
Actelion Pharmaceuticals

US Patent
LigandPNGBDBM205880(US9255090, 349)
Affinity DataIC50:  0.5nMpH: 7.0 T: 2°CAssay Description:Binding assay was performed in a final assay volume of 250 ul. First, 25 ul of test compound, previously diluted in Binding-Buffer (Binding-Buffer: 5...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetProstaglandin D2 receptor 2(Homo sapiens (Human))
Actelion Pharmaceuticals

US Patent
LigandPNGBDBM205881(US9255090, 350)
Affinity DataIC50:  8.20nMpH: 7.0 T: 2°CAssay Description:Binding assay was performed in a final assay volume of 250 ul. First, 25 ul of test compound, previously diluted in Binding-Buffer (Binding-Buffer: 5...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetProstaglandin D2 receptor 2(Homo sapiens (Human))
Actelion Pharmaceuticals

US Patent
LigandPNGBDBM205882(US9255090, 351)
Affinity DataIC50:  3.10nMpH: 7.0 T: 2°CAssay Description:Binding assay was performed in a final assay volume of 250 ul. First, 25 ul of test compound, previously diluted in Binding-Buffer (Binding-Buffer: 5...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetProstaglandin D2 receptor 2(Homo sapiens (Human))
Actelion Pharmaceuticals

US Patent
LigandPNGBDBM205883(US9255090, 352)
Affinity DataIC50:  8.10nMpH: 7.0 T: 2°CAssay Description:Binding assay was performed in a final assay volume of 250 ul. First, 25 ul of test compound, previously diluted in Binding-Buffer (Binding-Buffer: 5...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetProstaglandin D2 receptor 2(Homo sapiens (Human))
Actelion Pharmaceuticals

US Patent
LigandPNGBDBM205884(US9255090, 353)
Affinity DataIC50:  1.20nMpH: 7.0 T: 2°CAssay Description:Binding assay was performed in a final assay volume of 250 ul. First, 25 ul of test compound, previously diluted in Binding-Buffer (Binding-Buffer: 5...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetProstaglandin D2 receptor 2(Homo sapiens (Human))
Actelion Pharmaceuticals

US Patent
LigandPNGBDBM205885(US9255090, 354)
Affinity DataIC50:  4.20nMpH: 7.0 T: 2°CAssay Description:Binding assay was performed in a final assay volume of 250 ul. First, 25 ul of test compound, previously diluted in Binding-Buffer (Binding-Buffer: 5...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetProstaglandin D2 receptor 2(Homo sapiens (Human))
Actelion Pharmaceuticals

US Patent
LigandPNGBDBM205886(US9255090, 355)
Affinity DataIC50:  10.3nMpH: 7.0 T: 2°CAssay Description:Binding assay was performed in a final assay volume of 250 ul. First, 25 ul of test compound, previously diluted in Binding-Buffer (Binding-Buffer: 5...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetProstaglandin D2 receptor 2(Homo sapiens (Human))
Actelion Pharmaceuticals

US Patent
LigandPNGBDBM205887(US9255090, 356)
Affinity DataIC50:  2.10nMpH: 7.0 T: 2°CAssay Description:Binding assay was performed in a final assay volume of 250 ul. First, 25 ul of test compound, previously diluted in Binding-Buffer (Binding-Buffer: 5...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetProstaglandin D2 receptor 2(Homo sapiens (Human))
Actelion Pharmaceuticals

US Patent
LigandPNGBDBM205888(US9255090, 357)
Affinity DataIC50:  1.60nMpH: 7.0 T: 2°CAssay Description:Binding assay was performed in a final assay volume of 250 ul. First, 25 ul of test compound, previously diluted in Binding-Buffer (Binding-Buffer: 5...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetProstaglandin D2 receptor 2(Homo sapiens (Human))
Actelion Pharmaceuticals

US Patent
LigandPNGBDBM205889(US9255090, 358)
Affinity DataIC50:  1.10nMpH: 7.0 T: 2°CAssay Description:Binding assay was performed in a final assay volume of 250 ul. First, 25 ul of test compound, previously diluted in Binding-Buffer (Binding-Buffer: 5...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetProstaglandin D2 receptor 2(Homo sapiens (Human))
Actelion Pharmaceuticals

US Patent
LigandPNGBDBM205731(US9255090, 200 | US9255090, 201 | US9255090, 359)
Affinity DataIC50:  0.600nMpH: 7.0 T: 2°CAssay Description:Binding assay was performed in a final assay volume of 250 ul. First, 25 ul of test compound, previously diluted in Binding-Buffer (Binding-Buffer: 5...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetProstaglandin D2 receptor 2(Homo sapiens (Human))
Actelion Pharmaceuticals

US Patent
LigandPNGBDBM205891(US9255090, 360)
Affinity DataIC50:  6.10nMpH: 7.0 T: 2°CAssay Description:Binding assay was performed in a final assay volume of 250 ul. First, 25 ul of test compound, previously diluted in Binding-Buffer (Binding-Buffer: 5...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetProstaglandin D2 receptor 2(Homo sapiens (Human))
Actelion Pharmaceuticals

US Patent
LigandPNGBDBM205892(US9255090, 361)
Affinity DataIC50:  2.20nMpH: 7.0 T: 2°CAssay Description:Binding assay was performed in a final assay volume of 250 ul. First, 25 ul of test compound, previously diluted in Binding-Buffer (Binding-Buffer: 5...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
Displayed 1 to 50 (of 1422 total ) | Next | Last >>
Jump to: